GW PHARMACEUTICALS PLC Increase (Decrease) in Inventories
GW PHARMACEUTICALS PLC reported Increase (Decrease) in Inventories of $7.91 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2021-05-03
- GW PHARMACEUTICALS PLC increase (decrease) in inventories for the quarter ending 2021-03-31 was $7.91M, a 11.38% decline year-over-year.
- GW PHARMACEUTICALS PLC increase (decrease) in inventories for the quarter ending 2020-12-31 was $8.69M, a 35.94% decline year-over-year.
- GW PHARMACEUTICALS PLC increase (decrease) in inventories for the quarter ending 2020-09-30 was $11.52M, a 9.76% increase year-over-year.
- GW PHARMACEUTICALS PLC increase (decrease) in inventories for the quarter ending 2020-06-30 was $10.74M, a 15.92% decline year-over-year.
- GW PHARMACEUTICALS PLC increase (decrease) in inventories for fiscal 2020 was $39.87M, a 22.01% decline from fiscal 2019.
- GW PHARMACEUTICALS PLC increase (decrease) in inventories for fiscal 2019 was $51.13M.
- GW PHARMACEUTICALS PLC increase (decrease) in inventories for fiscal 2018 was $13.65M.
- GW PHARMACEUTICALS PLC increase (decrease) in inventories for fiscal 2017 was -$5.00K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2021-03-31 | $7.91M 10-Q · filed 2021-05-03 | $16.60M derived: sum of 2 quarters · filed 2021-05-03 | $28.12M derived: sum of 3 quarters · filed 2021-05-03 | $38.86M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | $8.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $20.20M derived: sum of 2 quarters · filed 2021-02-26 | $30.95M derived: sum of 3 quarters · filed 2021-02-26 | $39.87M 10-K · filed 2021-02-26 |
| 2020-09-30 | $11.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $22.26M derived: sum of 2 quarters · filed 2020-11-05 | $31.18M 10-Q · filed 2020-11-05 | $44.75M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | $10.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $19.67M 10-Q · filed 2020-08-07 | $33.23M derived: sum of 3 quarters · filed 2021-05-03 | $43.72M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | $8.93M 10-Q · filed 2021-05-03 | $22.49M derived: sum of 2 quarters · filed 2021-05-03 | $32.98M derived: sum of 3 quarters · filed 2021-05-03 | $45.76M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $13.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $24.05M derived: sum of 2 quarters · filed 2021-02-26 | $36.83M derived: sum of 3 quarters · filed 2021-02-26 | $51.13M 10-K · filed 2021-02-26 |
| 2019-09-30 | $10.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $23.27M derived: sum of 2 quarters · filed 2020-11-05 | $37.56M 10-Q · filed 2020-11-05 | $52.02M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $12.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $27.07M 10-Q · filed 2020-08-07 | $41.53M derived: sum of 3 quarters · filed 2021-02-26 | $58.05M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $14.29M 10-Q · filed 2020-05-11 | $28.75M derived: sum of 2 quarters · filed 2021-02-26 | $45.28M derived: sum of 3 quarters · filed 2021-02-26 | $43.45M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $14.46M 10-K · filed 2021-02-26 | $30.98M derived: sum of 2 quarters · filed 2021-02-26 | $29.16M derived: sum of 3 quarters · filed 2021-02-26 | $28.48M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | $16.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $14.70M derived: sum of 2 quarters · filed 2019-11-06 | $14.02M 10-Q · filed 2019-11-06 | $13.65M 10-K · filed 2021-02-26 |
| 2018-06-30 | -$1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$2.50M 10-Q · filed 2019-08-07 | -$2.88M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-03-31 | -$672.00K 10-Q · filed 2019-05-08 | -$1.05M derived: sum of 2 quarters · filed 2021-02-26 | ||
| 2017-12-31 | -$378.00K 10-K · filed 2021-02-26 | |||
| 2017-09-30 | -$5.00K 10-K · filed 2020-02-27 | |||
| 2016-09-30 | -$656.00K 10-KT · filed 2019-02-28 |